Valuation: Eckert & Ziegler SE

Market Cap 937M 1.03B 867M 782M 1.47B 96.05B 1.53B 10.47B 4.14B 51.85B 3.86B 3.78B 164B P/E 2026 *
18.3x
P/E 2027 * 17.3x
Enterprise Value 821M 900M 759M 685M 1.29B 84.09B 1.34B 9.16B 3.62B 45.39B 3.38B 3.31B 143B EV / Sales 2026 *
2.58x
EV / Sales 2027 * 2.38x
Free-Float
67.36%
Yield 2026 *
1.4%
Yield 2027 * 1.44%
1 day+0.90%
1 week+7.54%
Current month+12.63%
1 month+17.49%
3 months+12.38%
6 months+3.03%
Current year-1.83%
1 week 14.39
Extreme 14.39
15.71
1 month 12.52
Extreme 12.52
15.71
Current year 11.91
Extreme 11.91
16.84
1 year 11.91
Extreme 11.91
16.84
3 years 10.91
Extreme 10.913333
23.25
5 years 9.64
Extreme 9.639999
36.03
10 years 1.85
Extreme 1.845416
47.13
Manager TitleAgeSince
Chief Executive Officer 59 06/06/2023
Chief Tech/Sci/R&D Officer - 31/12/2024
Chief Operating Officer 59 31/12/2024
Director TitleAgeSince
Chairman 57 06/06/2023
Director/Board Member 66 31/12/2013
Director/Board Member 58 31/12/2016
Date Insider Type Main position Quantity % Market Cap. Importance
26/03/24 Sell

Founder

6,720 0.0317%
26/03/24 Buy

Founder

6,720 0.0317%
30/08/23 Sell

Founder

48,000 0.2267%
Change 5-day change 1-year change 3-year change Capi.($)
+0.74%+7.54%-5.43%+13.54% 1.03B
+0.87%-3.48%+20.26%+48.52% 257B
+1.24%-2.86%+1.36%+10.01% 161B
-2.23%-6.36%-23.01%+37.89% 146B
+1.42%-3.30%-56.02%-19.69% 63.26B
-0.19%-0.55%+25.21%+57.29% 60.51B
+1.25%+0.74%+5.46%-12.39% 53.46B
+2.97%+0.21%+23.28%+56.72% 49.99B
-3.89%-9.05%+1.27%+57.02% 44.88B
+3.63%-1.02%+23.76%+77.98% 45.81B
Average +0.48%-2.30%+1.61%+32.69% 88B
Weighted average by Cap. +0.37%-3.94%+2.99%+34.15%

Financials

2026 *2027 *
Net sales 319M 349M 295M 266M 501M 32.65B 520M 3.56B 1.41B 17.62B 1.31B 1.28B 55.65B 342M 376M 317M 286M 538M 35.09B 559M 3.82B 1.51B 18.94B 1.41B 1.38B 59.81B
Net income 51.68M 56.67M 47.78M 43.12M 81.21M 5.3B 84.42M 577M 228M 2.86B 213M 208M 9.03B 53.08M 58.21M 49.08M 44.29M 83.42M 5.44B 86.71M 593M 234M 2.94B 218M 214M 9.27B
Net Debt -117M -128M -108M -97.43M -183M -11.96B -191M -1.3B -515M -6.46B -480M -470M -20.39B -123M -135M -114M -103M -194M -12.62B -201M -1.38B -544M -6.81B -507M -496M -21.51B
Projected Income Statement - Annual - Eckert & Ziegler SE
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
1,131
Date Price Change Volume
18/11/26 €14.98 +0.74% 54,916
17/11/26 €14.87 -3.88% 80,006
16/11/26 €15.47 +0.85% 135,840
13/11/26 €15.34 +5.79% 319,505
12/11/26 €14.50 +4.09% 144,876
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Eckert & Ziegler SE
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
14.98EUR
Average target price
21.93EUR
Spread / Average Target
+46.42%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Eckert & Ziegler SE